Muna Therapeutics

Neurons may be more well known, but #DYK that microglia outnumber them almost 3:1? Microglia and astrocytes play essential roles in the central nervous system, contributing to many functions, including homeostasis, innate immune responses and synaptic support. #BrainAwarenessWeek

Age is the greatest factor for developing #NeurodegenerativeDisease, the gradual and progressive loss of brain cells, leading to cognitive and other dysfunction. The most common, #Alzheimers and #Parkinsons, impact a combined 7+ million people in the US. #BrainAwarenessWeek

We’re heading to San Francisco next week for @JPMorgan #JPM23. Looking forward to sharing the progress we’ve made on our brain resilience-centered approach to treating #neurodegenerative diseases like #Alzheimers, #Parkinsons, and #MS.

Looking forward to participating in the panel discussion on cross-border collaborations at the @longwoodleaders Pre-JPM web conference on Friday.

The @MichaelJFoxOrg grant will fund continued #preclinical investigations of novel, brain-exposed, small molecule potassium channel type 1.3 (Kv1.3) blockers. Learn more about @muna_tx here: munatherapeutics.com #biotech #research #neuroscience #MJFF #neurodegeneration

@muna_tx has been #awarded a $4.9m grant from @MichaelJFoxOrg to support ongoing #preclinical research and development of disease-modifying #therapy for #patients with #Parkinsons Read more: bit.ly/3ExYqk2 #biotech #research #neuroscience #MJFF #neurodegeneration

@muna_tx today announces the appointment of Dr. Niels Plath, an experienced CNS drug discovery and development leader, as Chief Scientific Officer. Read more at munatherapeutics.com #munatherapeutics #biotech #growth #cns

@muna_tx discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia and Parkinson's. #munatherapeutics #biotech #neurodegenerativediseases #growth

@muna_tx are delighted to announce the appointment of industry leader with expertise in building successful biotechnology companies Donald Nicholson, Ph.D., as independent Chair of Board of Directors. Read more: bit.ly/3C4cgWG #munatherapeutics #biotech #growth

We focus our groundbreaking science on identifying new medicines to preserve cognition and other brain functions and enhance resilience to neurodegenerative diseases. Our name reflects this focus: Muna means ‘to remember’ in Old Norse. Read more here: bit.ly/3k0mCkO

We are delighted to announce that we have successfully launched with US$ 73M Series A to advance novel small molecule therapeutics for neurodegenerative diseases Read more: bit.ly/3qVLjjw #munatherapeutics #biotech #neurodegenerativediseases